Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.

Autor: Peluso MJ; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA., Takahashi S; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA., Hakim J; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA., Kelly JD; Department of Epidemiology and Biostatistics, University of California, San Francisco, USA., Torres L; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA.; Division of Experimental Medicine, University of California, San Francisco, USA., Iyer NS; Division of Experimental Medicine, University of California, San Francisco, USA., Turcios K; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA., Janson O; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA., Munter SE; Division of Experimental Medicine, University of California, San Francisco, USA., Thanh C; Division of Experimental Medicine, University of California, San Francisco, USA., Nixon CC; Division of Experimental Medicine, University of California, San Francisco, USA., Hoh R; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA., Tai V; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA., Fehrman EA; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA., Hernandez Y; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA., Spinelli MA; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA., Gandhi M; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA., Palafox MA; Abbott Laboratories, Abbott Park, IL, USA., Vallari A; Abbott Laboratories, Abbott Park, IL, USA., Rodgers MA; Abbott Laboratories, Abbott Park, IL, USA., Prostko J; Abbott Laboratories, Abbott Park, IL, USA., Hackett J Jr; Abbott Laboratories, Abbott Park, IL, USA., Trinh L; Monogram Biosciences, Inc., South San Francisco, CA, USA., Wrin T; Monogram Biosciences, Inc., South San Francisco, CA, USA., Petroplolous CJ; Monogram Biosciences, Inc., South San Francisco, CA, USA., Chiu CY; Department of Laboratory Medicine, University of California, San Francisco, USA.; Division of Infectious Diseases, University of California, San Francisco, USA.; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, USA., Norris PJ; Vitalant Research Institute, San Francisco, CA, USA., DiGermanio C; Vitalant Research Institute, San Francisco, CA, USA., Stone M; Vitalant Research Institute, San Francisco, CA, USA., Busch MP; Department of Laboratory Medicine, University of California, San Francisco, USA.; Vitalant Research Institute, San Francisco, CA, USA., Elledge SK; Department of Pharmaceutical Chemistry, University of California, San Francisco, USA., Zhou XX; Department of Pharmaceutical Chemistry, University of California, San Francisco, USA., Wells JA; Department of Pharmaceutical Chemistry, University of California, San Francisco, USA.; Department of Cellular & Molecular Pharmacology, University of California, San Francisco, USA., Shu A; Department of Laboratory Medicine, University of California, San Francisco, USA., Kurtz TW; Department of Laboratory Medicine, University of California, San Francisco, USA., Pak JE; Chan Zuckerberg Biohub, San Francisco, USA., Wu W; Chan Zuckerberg Biohub, San Francisco, USA., Burbelo PD; National Institute of Dental Research, National Institutes of Health, Bethesda, USA., Cohen JI; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA., Rutishauser RL; Division of Experimental Medicine, University of California, San Francisco, USA., Martin JN; Department of Epidemiology and Biostatistics, University of California, San Francisco, USA., Deeks SG; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA., Henrich TJ; Division of Experimental Medicine, University of California, San Francisco, USA., Rodriguez-Barraquer I; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA., Greenhouse B; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2021 Mar 05. Date of Electronic Publication: 2021 Mar 05.